CAPLIPOINT

Caplin Point Laboratories Share PriceCaplin Point Laboratories

₹592.00
7.85 (1.34%)
As on 30 March, 2023 | 19:10 BSE: 524742 NSE: CAPLIPOINT

Caplin Point Laboratories Performance

Day Range

  • Low
  • High

52 Week Range

  • Low
  • High
  • Open Price
  • Previous Close
  • Volume

Start SIP in Caplin Point Laboratories

Start SIP

Caplin Point Laboratories Share Price

  • Over 1 Month -9.38%
  • Over 3 Month -16.71%
  • Over 6 Month -18.79%
  • Over 1 Year -14.06%

Caplin Point Laboratories Key Statistics

P/E Ratio 12.7
PEG Ratio 0.6
Market Cap Cr 4,493
Price to Book Ratio 3.1
EPS 24.7
Dividend 0.7
Relative Strength Index 29.5
Money Flow Index 60.88
MACD Signal -20.24
Average True Range 19.14

Caplin Point Laboratories Investment Rating

  • Master Rating:
  • Caplin Point Labs. has an operating revenue of Rs. 1,416.69 Cr. on a trailing 12-month basis. An annual revenue growth of 21% is outstanding, Pre-tax margin of 30% is great, ROE of 21% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 93 which is a GREAT score indicating consistency in earnings, a RS Rating of 35 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at E which indicates heavy supply, Group Rank of 84 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Caplin Point Laboratories Financials
IndicatorDec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 131137116112
Operating Expenses Qtr Cr 79807074
Operating Profit Qtr Cr 52574638
Depreciation Qtr Cr 6767
Interest Qtr Cr 0000
Tax Qtr Cr 15161113
Net Profit Qtr Cr 59586329

Caplin Point Laboratories Technicals

EMA & SMA

Current Price
₹592.
7.85 (1.34%)
  • Bullish Moving Average
  • ___
  • 0
  • Bearish Moving Average
  • ___
  • 16
  • 20 Day
  • 623.94
  • 50 Day
  • 657.5
  • 100 Day
  • 685.55
  • 200 Day
  • 709.26
  • 20 Day
  • 629.42
  • 50 Day
  • 665.6
  • 100 Day
  • 699.65
  • 200 Day
  • 723.08

Caplin Point Laboratories Resistance and Support

PIVOT
₹587.72
Resistance
First Resistance 595.44
Second Resistance 606.72
Third Resistance 614.44
RSI 29.5
MFI 60.88
MACD Single Line -20.23
MACD -23.09
Support
First Resistance 576.44
Second Resistance 568.72
Third Resistance 557.44

Caplin Point Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 173,415 9,888,123 57.02
Week 107,284 6,714,881 62.59
1 Month 143,350 6,032,168 42.08
6 Month 66,140 2,996,147 45.3

Caplin Point Laboratories Result Highlights

Caplin Point Laboratories Synopsis

NSE-Medical-Generic Drugs

Caplin Point Lab is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 528.06 Cr. and Equity Capital is Rs. 15.16 Cr. for the Year ended 31/03/2022. Caplin Point Laboratories Ltd. is a Public Limited Listed company incorporated on 16/04/1990 and has its registered office in the State of Tamil Nadu, India. Company’s Corporate Identification Number(CIN) is L24231TN1990PLC019053 and registration number is 019053.
Market Cap 4,497
Sales 496
Shares in Float 2.35
No of funds 82
Yield 0.68
Book Value 4.83
U/D Vol ratio 1
LTDebt / Equity
Alpha -0.02
Beta 0.67

Caplin Point Laboratories

Owner NameDec-22Sep-22Jun-22Mar-22
Promoters 68.8%68.88%68.88%
Mutual Funds 1.04%1.05%1.06%
Foreign Portfolio Investors 2.24%2.15%2.03%
Financial Institutions/ Banks
Individual Investors 18.91%19%20.77%
Others 9.01%8.92%7.26%

Caplin Point Laboratories Management

Name Designation
Mr. C C Paarthipan Chairman
Dr. Sridhar Ganesan Managing Director
Mr. V Thirumalai Independent Director
Mr. R Viswanathan Independent Director
Mr. D Sathyanarayanan Independent Director
Dr. C K Gariyali Independent Director

Caplin Point Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Caplin Point Laboratories MF Shareholding

Name Amount(cr)
Quant Small Cap Fund Growth 3302
Quant Tax Plan Growth 2779
Nippon India Nifty Smallcap 250 Index Fund Reg Gr 388
Motilal Oswal Nifty 500 Fund Regular Growth 372
Motilal Oswal Nifty Smallcap 250 Index Fund Regular Growth 313

Caplin Point Laboratories FAQs

What is Share Price of Caplin Point Laboratories ?

Caplin Point Laboratories share price is ₹592 As on 30 March, 2023 | 18:56

What is the Market Cap of Caplin Point Laboratories ?

The Market Cap of Caplin Point Laboratories is ₹4493.4 Cr As on 30 March, 2023 | 18:56

What is the P/E ratio of Caplin Point Laboratories ?

The P/E ratio of Caplin Point Laboratories is 12.7 As on 30 March, 2023 | 18:56

What is the PB ratio of Caplin Point Laboratories ?

The PB ratio of Caplin Point Laboratories is 3.1 As on 30 March, 2023 | 18:56

Q2FY23

Start Investing Now!

Open Free Demat Account in 5 mins

Enter Valid Mobile Number